Mount Sinai School of Medicine presents its 7th annual research symposium, New Insights into Diagnosis, Neurobiology, Genetics and Treatment of Autism, presented by the Department of Psychiatry and the Page & William Black Post-Graduate School at Mount Sinai. The event is scheduled for Sunday, Nov. 2 and will take place in the Stern Auditorium at the Mount Sinai School of Medicine in New York City.
For more information or to register for the conference, click on the following link:
The symposium features presentations by Thomas Insel, M.D., director of the National Institute of Mental Health; U.S. Senator Charles E. Schumer (NY); and NAAR-funded researcher Simon Baron-Cohen, Ph.D., director of the Autism Research Centre at Cambridge University.
NAAR co-founder, Eric London, M.D., is a member of the symposium guest faculty and is taking part in a workshop on advocacy and support groups in autism.
In addition to Dr. Cohen, other NAAR-funded researchers presenting at the symposium include Allison McInnes, M.D., of the Department of Psychiatry and Human Genetics at Mount Sinai; Helen Tager-Flusberg, Ph.D., of the Department of Anatomy and Neurobiology at Boston University School of Medicine; and Rebecca Landa, Ph.D., director of the Center for Autism and Related Disorders at Kennedy Krieger Institute.
The symposium is designed to update and enhance the knowledge of the practicing psychiatrist, neurologist, other healthcare professionals, teachers and family members as to the accurate recognition and diagnosis of autism spectrum disorders. This meeting will help attendees understand current neurological, functional imaging, neurotransmitter and molecular biology models of autism; understand how autism may run in families; become familiar with current pharmacological, social skills and support group treatment of autism spectrum disorders.
For more information on the symposium, please contact Karen Zagursky at (212) 241-7098 or via e-mail at